Aktie A2QML9 MICROPORT CARDIOFLOW MEDTECH CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen MicroPort CardioFlow Medtech Corporation

Aktien

A2QML9

KYG6082P1054

2160

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:16 24.04.2024 		% 5 Tage % 1. Jan.
0,98 HKD +1,03 % Intraday Chart für MicroPort CardioFlow Medtech Corporation +4,26 % -39,51 %
15.04. MicroPort CardioFlow Medtech Corporation schließt den 2024 MP CardioAdvent Service Procurement Rahmenvertrag ab CI
27.03. MicroPort CardioFlow Medtech Corporation berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Microport Cardioflow Inks Services Deal with Subsidiary
MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
MicroPort CardioFlow Medtech Corporation Provides Consolidated Revenue Guidance for the Year Ended December 31, 2023
China Approves MicroPort CardioFlow's Application for Atrial Appendage Closure System; Shares Fall 3%
Microport Cardioflow Medtech Corporation Receives NMPA Approval for Registration Application of Anchorman LAAC System
MicroPort CardioFlow Subsidiary to Buy 51% Stake in Medical Device Maker
MicroPort CardioFlow Medtech to Renew Four Agreements With Parent
MicroPort's Transcatheter Aortic Heart-Valve Implantation Product Completes Seven Trials in Europe
MicroPort CardioFlow Medtech Corporation Completes Clinical Implantation Cases in Europe
MicroPort CardioFlow's Transcatheter Aortic Heart Valve Implantation Device Enters Clinical Application Phase
MicroPort CardioFlow Medtech Corporation Announces First Two Clinical Applications of Third-Generation TAVI Product
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
MicroPort Cardioflow Medtech Corporation Announces Executive Changes
MicroPort Cardioflow Medtech Corporation Announces Executive Changes
Microport Cardioflow Medtech Corporation Announces Change of Directors and Chairman,Change in Composition of Board Committees,Change of President and Change of Authorised Representative
MicroPort CardioFlow's TMVR System Passes Clinical Trials
MicroPort CardioFlow Medtech Corporation Announces Self-Developed TMVR System Achieved Excellent Follow-Up Results in Multiple Clinical Application Cases
MicroPort CardioFlow Medtech to Grant 10 Million Share Options
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QML9 Aktie
  4. Nachrichten MicroPort CardioFlow Medtech Corporation
  5. Andere Sprachen